Sweet Earth Holdings (SE) AI Stock Analysis

• Market Cap: C$6.59M
• Dividend Yield: N/A
• Average Volume (3M): 148.00
• Price to Earnings (P/E): 2.1
• Beta (1Y): -0.53
• Revenue Growth: -100.01%
• EPS Growth: N/A
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 44
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.03
• Shares Outstanding: 12,915,026
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 148
• PEG Ratio: -0.07
• Price to Book (P/B): -2.27
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -9.95
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 40 Underperform
• Price Target: ―

Sweet Earth Holdings faces significant financial instability with negative equity and persistent losses, posing high financial risks. Despite some technical strength and an attractive valuation, these factors are overshadowed by severe financial challenges and reliance on external funding. The recent private placement may provide short-term relief but does not address the underlying operational issues.

Sweet Earth Holdings Business Overview & Revenue Model

Company Description

Sweet Earth Holdings (SE) is a diversified company operating in the health and wellness sector, specializing in the development, production, and distribution of premium plant-based products. The company focuses on offering a broad range of innovative goods such as plant-based foods, cosmetics, and wellness products, catering to consumers seeking healthier and sustainable lifestyle choices.

How the Company Makes Money

Sweet Earth Holdings makes money through multiple revenue streams primarily driven by the sale of its plant-based products. The company generates revenue from the direct sale of its consumer goods through retail and online channels. Additionally, Sweet Earth Holdings may engage in strategic partnerships and collaborations with other companies to expand its market reach and enhance product offerings, further contributing to its earnings. The company's focus on innovation and quality allows it to maintain competitive pricing and attract a dedicated customer base, which is crucial for sustaining its revenue growth.

Sweet Earth Holdings Financial Statement Overview

Summary

Sweet Earth Holdings is facing severe financial challenges across all verticals. The company's declining revenues, persistent losses, and negative equity position highlight significant operational and financial risks. The reliance on external financing further emphasizes the need for strategic restructuring to improve financial health.

Income Statement

Sweet Earth Holdings has experienced a significant decline in revenue over the years, with TTM (Trailing-Twelve-Months) revenue even turning negative. The gross profit margin is negative, indicating cost management issues. The company has been consistently operating at a loss, shown by negative EBIT and net income figures, despite some improvement in EBITDA. These factors highlight ongoing challenges in achieving profitability.

Balance Sheet

The company's balance sheet is highly leveraged, with negative stockholders' equity indicating insolvency risk. The debt-to-equity ratio is not calculable due to negative equity, and the equity ratio is also negative. Overall, the balance sheet reflects financial instability and high financial risk.

Cash Flow

The cash flow statements show negative operating and free cash flows, indicating poor cash generation from operations. While financing activities have provided some liquidity, the reliance on external funding is unsustainable in the long term. The company's cash flow to net income ratios suggest inefficiencies in converting profits into cash.

Breakdown	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	9.67K	42.25K	88.12K	200.72K	0.00
Gross Profit	5.58K	30.30K	38.44K	107.56K	1.75M
EBITDA	183.15K	43.52K	-2.85M	-4.61M	-4.58M
Net Income	182.92K	-117.87K	-3.15M	-4.92M	-3.34M
Balance Sheet
Total Assets	17.70K	167.51K	1.28M	3.18M	6.30M
Cash, Cash Equivalents and Short-Term Investments	17.70K	155.05K	134.60K	84.83K	21.21K
Total Debt	50.23K	29.94K	1.11M	1.20M	1.85M
Total Liabilities	304.89K	640.80K	2.12M	2.30M	3.45M
Stockholders Equity	-287.19K	-473.29K	-840.34K	880.96K	2.84M
Cash Flow
Free Cash Flow	-165.52K	-491.70K	-883.00K	-4.42M	-2.90M
Operating Cash Flow	-165.52K	-491.70K	-863.85K	-3.57M	-2.05M
Investing Cash Flow	0.00	0.00	-19.16K	-851.17K	-851.17K
Financing Cash Flow	25.00K	525.00K	1.03M	3.64M	2.56M

Sweet Earth Holdings Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.51
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:SE, the sentiment is Negative. The current price of 0.51 is equal to the 20-day moving average (MA) of 0.51, below the 50-day MA of 0.51, and above the 200-day MA of 0.40, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 44.63 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:SE.

Sweet Earth Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OGI	71 Outperform	$266.43M	19.21	4.76%	―	26.93%	―
ACB	51 Neutral	$344.79M	107.55	3.05%	―	26.98%	―
CWEB	50 Neutral	C$19.03M	―	-78.03%	―	-11.84%	20.29%
TLRY	49 Neutral	$625.68M	―	-31.06%	―	11.22%	-108.58%
Sector *	46 Neutral	C$197.02M	-3.33	-23.14%	2.65%	20.75%	-0.36%
SE	40 Underperform	C$6.59M	2.06		―	-100.01%	―
WEED	39 Underperform	$315.66M	―	-122.10%	―	-18.39%	35.21%

Sweet Earth Holdings Corporate Events

Sweet Earth Holdings Announces Reverse Takeover with Vesalius Longevity Labs

Sweet Earth Holdings Corporation has entered into a binding letter of intent with Vesalius Longevity Labs and its SPV to combine their businesses through a reverse takeover. This transaction will result in Vesalius and SPV shareholders owning approximately 82.5% of the new entity, subject to various conditions including regulatory approvals and a concurrent financing of at least CAD $10 million.